Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL’s logo at company headquarters. The Menlo Park biotech specializes in blood-based early cancer screening through its Galleri test news.samsung.com tradingview.com. GRAIL, Inc. is focused on early cancer detection – its mission is “to detect cancer early when it can be cured” news.samsung.com. The company’s Galleri test analyzes tumor DNA in blood to screen for dozens of cancers in asymptomatic adults. Recently, two developments have driven the stock: Samsung’s strategic deal and positive trial data. These moves suggest GRAIL is gaining traction, but they also highlight the challenges ahead in turning cutting-edge science into profit.
18 October 2025
···
Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney’s share price has been relatively flat in 2025 after rallying in 2024. As of Oct. 17 the stock sat around $110.7 marketbeat.com, roughly unchanged from early January. Over the last few days DIS has traded in a narrow $109–112 range stockanalysis.com. Year-to-date Disney is up only ~0.8% benzinga.com, underperforming the broader market rally. In late September and early October the stock dipped into the high-$100s, but analysts say any pullback may present a buying opportunity given Disney’s upcoming catalysts.
18 October 2025
·
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple’s stock is trading near record levels as of mid-October 2025. Last week, AAPL shares oscillated in the $247–$252 range, closing at $252.29 on Oct. 17 historicalstockprice.com. That is only a few dollars below the all-time intraday high set in late September ts2.tech historicalstockprice.com. Technically, AAPL is above both its 50-day and 200-day moving averages ts2.tech, signaling positive momentum. However, the stock’s 2025 performance has been muted: it is up only about 1–2% on the year ts2.tech. This flatness contrasts sharply with many other mega-cap tech stocks: for example, Nvidia is +35% YTD, Microsoft +23%, and Alphabet +29% ts2.tech. Apple’s more modest gain reflects its already-lofty valuation and the market’s shift toward hyper-growth AI names ts2.tech ts2.tech. Nonetheless, with roughly a $3.8 trillion market cap, Apple remains a cornerstone holding known for its stable cash flows.
18 October 2025
···
GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace shares have been on a tear in 2025, roughly doubling from lows. As of Oct 17, 2025, the stock closed around $300 reuters.com. That’s up about 78% this year intelligentinvestor.com.au – one of the best performances among mega-cap industrials. The 52-week high is $307.25 and the low was $159.36 reuters.com, reflecting a remarkable rebound as the company emerged as a pure-play aerospace engine maker.
18 October 2025
··
IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM’s stock has rallied sharply in fall 2025. It closed around $279 on Oct 13 ts2.tech, just shy of its late-September peak near $296 ts2.tech. Investors point to IBM’s pivot to AI, cloud and quantum computing as catalysts. In late September, the company announced a first-of-its-kind quantum computing trial with HSBC, which used IBM’s quantum processor to improve bond-trading forecasts by 34% reuters.com. HSBC’s Philip Intallura said the trial is “a tangible example of how today’s quantum computers could solve a real-world business problem at scale” reuters.com. The news helped fuel IBM’s stock jump into October.
18 October 2025
···
Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Atai shares exploded higher on Oct. 17, 2025. Investors bid the stock up ~17.7%, closing at roughly $6.45 ts2.tech. In after-hours trading it briefly touched ~$6.86 ts2.tech. This rally follows a week of good news: BPL-003’s FDA breakthrough, plus well-received capital raise plans. Volume on Oct. 17 was very high, reflecting heavy trading. Over 2025 the stock has skyrocketed ~348% ts2.tech, making ATAI one of the year’s top biotech performers. Its market cap now hovers around $1.2 billion ts2.tech.
18 October 2025
·
Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

CSCO Stock Climbs on Strong Quarter: Cisco’s stock has steadily climbed in 2025, even as many tech peers swung wildly during the AI frenzy. As of mid‑October, CSCO is trading just below its year-high ts2.tech ts2.tech. Over the past week the stock added roughly 2% on investor optimism around recent announcements ts2.tech. Market observers note Cisco’s low volatility and broad support: shares have stayed above key moving averages ts2.tech. “Cisco’s stock has been a steady performer in 2025,” TechStock² notes, ~31% higher than a year ago ts2.tech. The company’s market cap is now ~$270 billion, making it one of the largest tech firms by value ts2.tech.
18 October 2025
···
New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era’s stock has rocketed in October thanks to its high-profile push into AI data centers. Mid-September it rebranded from New Era Helium to New Era Energy & Digital, emphasizing its shift into “energy-enabled” digital infrastructure ts2.tech. The company’s 50/50 joint venture, Texas Critical Data Centers, is designing a 438-acre AI campus in West Texas with up to 1 GW of on-site power generation. News of its progress has drawn feverish investor interest: after TCDC completed Phase One engineering in late Sept., NUAI jumped nearly 50% in one day businesswire.com, and when it announced the start of Phase Two engineering on Oct. 6, the stock surged ~85% intraday on Oct. 9 ts2.tech ts2.tech.
18 October 2025
···
MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed’s stock has skyrocketed in recent weeks. After languishing in the single digits, MNMD climbed above $12 in late September and spiked to $13.09 on Oct. 14, its highest level in over a year ts2.tech marketbeat.com. The surge has pushed the stock roughly +68% year-to-date ts2.tech. Heavy trading volume accompanied the rise, as investors reacted to the latest clinical and regulatory news.
18 October 2025
·
Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

In mid-October 2025, Virgin Galactic’s stock was a top mover in the market. After languishing in the low-$3 range, SPCE shares rallied over 40% in early October on a wave of positive news ts2.tech. For example, on Oct. 16 alone the stock jumped about 6% intraday. Trading volume exploded as speculative traders piled in on hopes of new catalysts ts2.tech reuters.com. However, this enthusiasm was met by profit-taking almost immediately: by Oct. 17 the stock plunged 7.9%, erasing much of the gains and closing around $4.08 ts2.tech reuters.com. The volatile swings were driven by Virgin’s history of boom‑bust moves and heavy short interest ts2.tech ts2.tech. As TS2.tech noted, SPCE’s rollercoaster ride reflects its “high beta” nature – it “rockets upward on good news and then just as swiftly comes back to earth” ts2.tech. On Oct. 18 the Reuters market page listed SPCE at $4.08 reuters.com, far below its peaks of 2021 but still substantially above the mid-2025 lows.
18 October 2025
··
Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

As of mid-October 2025, Sellas Life Sciences trades around $2.10–2.20. This is near the top of its 52-week range and about twice its price at the start of 2025 stockanalysis.com marketbeat.com. Trading volume and volatility have picked up – for instance, on Oct. 14 a massive spike in call-option activity coincided with bullish sentiment marketbeat.com. The stock’s YTD gain far outpaces many small-cap biotechs. Technical platforms note SLS is in “uptrend” territory: the stock is well above its 20-day EMA and 50-day EMA tipranks.com, which TipRanks flags as “Buy” signals. Meanwhile, about 18% of shares are sold short marketbeat.com, a high level that could fuel further swings if any surprise news hits.
18 October 2025
··
Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s abrupt pivot to Chinese fighters has captured global attention. Defense analysts say it underscores Jakarta’s insistence on strategic autonomy. “Foreign actors can spread disinformation, but at the end of the day, Indonesia buys what it chooses,” writes analyst Muhammad Zulfikar Rakhmat asiatimes.com. In practice, Jakarta is “quietly demonstrating that strategic autonomy is possible” – fielding the latest jets from East and West while balancing great-power pressures asiatimes.com. For now, Southeast Asian neighbors and global arms makers will be watching closely how this deal unfolds and how it reshapes the region’s airpower balance.
18 October 2025
···
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics, a clinical-stage biotech developing the RaniPill® capsule for oral delivery of biologic drugs, was essentially flat around $0.45–$0.50 from mid-September through early October. On Oct. 17, it announced a collaboration with Chugai to turn one of Chugai’s injectable rare-disease antibodies into a pill formulation. The news, coupled with the new funding, ignited a buying frenzy ts2.tech. By mid-day Friday, RANI was up ~180% on the session ts2.tech, markedly outpacing the broader market’s modest gains.
18 October 2025
···
Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat’s brand remains visible to consumers, but behind the scenes its finances are in crisis. In mid-October 2025 the company announced an early settlement of its convertible debt exchange offer, triggering a historic market reaction. As Reuters reports, BYND shareholders are “agonizing” after the company offered existing bondholders new debt and stock in place of their $1.1 billion 2027 notes reuters.com globenewswire.com. With ~96.9% of noteholders participating, Beyond Meat will issue about $196.2 M in new 7.0% convertible notes plus a $12.5 M tender premium – roughly $208.7 M total – and 316.15 million new shares globenewswire.com globenewswire.com. In other words, each current share will face massive dilution.
18 October 2025
·
Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy’s logo has been in the spotlight as the stock rallied on the latest earnings. On October 17, one day after Liberty’s Q3 report, the stock soared ~28% intraday, closing at $15.32 reuters.com ts2.tech. That move came even though broader markets were relatively calm. Traders piled in on the “better-than-feared” outcome. By contrast, LBRT’s shares had been drifting lower for months; at one point earlier in Oct they were down over 40% on the year ts2.tech.
18 October 2025
···
Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

In summary, Gilead’s share price has rallied on a wave of HIV-related breakthroughs, pipeline achievements, and upbeat guidance. With third-quarter results due Oct. 30, investors will be watching for sustained growth. For now, analysts remain generally optimistic: the consensus rating is “Buy” based on Gilead’s diversified portfolio and innovation investing.com ts2.tech. As management shifts into high gear on oncology and global health programs, the long-term outlook is that Gilead’s multiple drivers will more than offset sector risks.
18 October 2025
·
Gold Mania 2025: Record Rally Shatters Records – $5,000 in Sight?

Gold Mania 2025: Record Rally Shatters Records – $5,000 in Sight?

Gold prices have soared this October, breaching $4,300/oz for the first time ever and up over 60% year-to-date reuters.com reuters.com. The safe-haven rally is driven by Fed rate-cut expectations, US political uncertainty and global tensions economictimes.indiatimes.com reuters.com. Analysts note no clear end to the rally: Metals Focus’s Matthew Piggott targets ~$5,000/oz absent a “major shift” ts2.tech, and HSBC now sees gold averaging near $5,000 by 2026 reuters.com reuters.com. In Asia, Diwali/Dhanteras festival buying has pushed Indian premiums to decade highs reuters.com, with domestic prices at ~₹1,31,700 per 10g reuters.com. Bullion flows are “insatiable” – record ETF inflows and heavy central bank buying underpin the surge ts2.tech reuters.com. Even silver joined the run – hitting a record ~$54.47/oz in mid-October reuters.com. Meanwhile US stocks ticked up as gold paused reuters.com, reflecting eased bank-credit worries and trade jitters.
18 October 2025
··
Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Hims & Hers’ expansion into menopause care was greeted with enthusiasm in the market. On October 15, the San Francisco–based telehealth provider announced it is now offering affordable treatment plans for women in perimenopause and menopause via its Hers platform businesswire.com businesswire.com. The move adds a new specialty to Hers, which already serves over 500,000 women subscribers businesswire.com. By connecting patients with providers trained in menopause care, Hims & Hers aims to fill a long-neglected gap in women’s health. “Women have been navigating an outdated healthcare system that wasn’t designed for them for too long. Hers was built to serve every woman on her terms,” said Dr. Jessica Shepherd, Chief Medical Officer of Hims & Hers businesswire.com businesswire.com. She noted that the goal is “building a platform that women can trust to access the care they need,” by increasing access to specialists for every life stage businesswire.com.
17 October 2025
·
Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Regions Financial’s stock has seen whipsaw volatility in recent days. Last week’s renewed banking sector fears – sparked by a $50 million fraud-related loan loss at Zions Bancorp and other credit worries – hit regional bank stocks hard, sending the KBW Regional Banking Index down over 6% on Oct. 16 ts2.tech. Regions was caught in that downdraft, with RF shares plunging about 5–6% on Thursday to close around $23.33 marketbeat.com, a multi-month low.
17 October 2025
··
VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

VirnetX shocked the market with an eye-popping rally on October 17, 2025, after unveiling a significant government deal. The Nevada-based cybersecurity firm announced it won a General Services Administration Multiple Award Schedule contract late Thursday, and by Friday’s open the stock exploded upward stocktwits.com. Shares opened 71% higher and briefly touched a level not seen in over two years stocktwits.com. The exuberance was directly tied to the GSA news, which investors interpreted as a game-changer for VirnetX’s federal business prospects.
17 October 2025
··
1 … 97 98 99 100 101 … 164

Stock Market Today

  • Rivian (RIVN) Trades Near Offering Level Before Crucial R2 Production News
    July 26, 2026, 1:09 PM EDT. Rivian (NASDAQ:RIVN) ended Friday at $15.84, marking a 9.2% decline for the week and hovering just 2.2% above its $15.50 offering price. The automaker targets 44,941 deliveries in the second half, nearly doubling the 22,559 vehicles delivered in the first half, which means an average of 22,471 units per quarter required. Following the issue of 86.25 million new shares, pro-forma cash totals $6.62 billion. Preliminary second-quarter revenue is forecast between $1.55 billion and $1.65 billion. The company will report earnings on July 30.